» Articles » PMID: 36219078

[Reactive Astrocytes in Brain Diseases: Therapeutic Targets and Biomarkers]

Overview
Journal Med Sci (Paris)
Date 2022 Oct 11
PMID 36219078
Authors
Affiliations
Soon will be listed here.
Abstract

Astrocytes are essential partners of neurons in the central nervous system. In response to many brain diseases, astrocytes change at the morphological, molecular and functional levels: they become reactive. These multiple changes are likely to have significant impacts on neurons, which are dependent on several astrocyte functions. Astrocyte reactivity is context-specific. It is therefore essential to determine the changes occurring in reactive astrocytes in each pathological situation, through dedicated and selective approaches. This will promote the development of innovative therapies that target the cellular partners of neurons, as well as the identification of specific disease biomarkers.

Citing Articles

Effect of metabolic disorders on reactive gliosis and glial scarring at the early subacute phase of stroke in a mouse model of diabetes and obesity.

Clain J, Couret D, Bringart M, Meilhac O, Lefebvre dHellencourt C, Diotel N IBRO Neurosci Rep. 2025; 18():16-30.

PMID: 39816479 PMC: 11733059. DOI: 10.1016/j.ibneur.2024.12.002.


Modeling the heterogeneity of sodium and calcium homeostasis between cortical and hippocampal astrocytes and its impact on bioenergetics.

Thapaliya P, Pape N, Rose C, Ullah G Front Cell Neurosci. 2023; 17:1035553.

PMID: 36794264 PMC: 9922870. DOI: 10.3389/fncel.2023.1035553.